Brief: Protagenic Therapeutics Announces Nasdaq Uplisting And Pricing Of $13.2 Mln Public Offering
27/04/2021 02:10
April 26 (Reuters) - Protagenic Therapeutics Inc PTIX.PK :
* PROTAGENIC THERAPEUTICS, INC. ANNOUNCES NASDAQ UPLISTING
AND PRICING OF $13.2 MILLION PUBLIC OFFERING
* PRICING OF PUBLIC OFFERING OF 3,180,000 UNITS AT A PUBLIC
OFFERING PRICE OF $4.15 PER UNIT
Source text for Eikon: ID:nGNX4M3Gzs
Further company coverage: PTIX.PK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Protagenic Therapeutics
See all newsBrief: Protagenic Therapeutics Inc - Alexander Arrow, CFO, To Be Terminated Effective April 30, 2026 - SEC Filing
Brief: Protagenic Therapeutics Approves Restructuring Plan on August 8- SEC Filing
Brief: Protagenic Therapeutics Granted Japanese Patent JP 7714571B
Brief: Protagenic Therapeutics Enters Share Exchange Agreement With Alterola And EMC2 - SEC Filing
Brief: Protagenic Therapeutics - May Offer And Sell, From Time To Time, Shares Of Common Stock Of Up To $1.2 Mln